Lawmakers and CVS executives spar in Phoenix over whether taxes, PBM rules or market fixes will lower drug costs.

Leerink Global Healthcare Conference 2026 March 9, 2026 8:40 AM EDTCompany ParticipantsPrem Shah - Executive VP & ...

Pelthos Therapeutics Inc. ( PTHS) Q4 2025 Earnings Call March 19, 2026 8:00 AM EDT ...

In a market flooded with wellness gadgets, Helio Cure is drawing a line in the sand. True healing shouldn't keep you awake at night. The company unveils its new flagship line of Red Light Therapy (RLT ...

Humana has notably underperformed the S&P 500 over the past year, but analysts are moderately optimistic about the stock’s prospects.

YCANTH® net revenue grew 130% to $15.3 million in 2025, and selling, general and administrative expenses decreased by over 40%, when compared ...

The president of the Tennessee Medical Association argues that newly proposed legislation will improve healthcare transparency and curb costs.

Fiscal stress reflects rates lagging medical trend; behavioral health utilization far exceeded assumptions (30% vs 3.5%–4%), ...

As a physician leader, I feel an obligation to respond to what has been said about healthcare providers by executives within the health insurance industry via recently published opinion pieces. ...

Purchaser coalition data show accelerating uptake: direct contracts rose from 18.7% (2023) to 27.6% (2025), with an additional 26.7% evaluating adoption over one to three years. Cost pressure remains ...

YCANTH® net revenue grew 130% to $15.3 million in 2025, and selling, general and administrative expenses decreased by over 40%, when compared to 2024 - - Company earned $35.6 million in total revenue ...

Rivera, an independent pharmacy payment integrity company, published a new issue brief examining why the current wave of PBM reform raises the bar for pharmacy benefit oversight without replacing the ...